Poland· PL-100192249
Epiduo
A adapalen, kombinationen product containing adapalenum + benzoylis peroxidum, registered in Poland by Galderma Polska Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Adapalen, kombinationen is registered in 12 of 19 countries.
Countries holding a registration under ATC D10AD53 (adapalen, kombinationen), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Adapalen, kombinationen · ATC D10AD53
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Adapalenum + Benzoylis peroxidum
- Manufacturer
- Galderma Polska Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- D10AD53
- ATC class
- Adapalen, Kombinationen
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
- gtin05909990642656
- gtin05909990642663
- gtin05909990652792
- gtin05909991100148
- gtin05909991100155
- gtin05909991100162
- gtin05909991100179
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under D10AD53
Adapalen, kombinationen, as other registers publish it.
- SwitzerlandAceduo Leman
- SwitzerlandAceduo Leman, GelLeman SKL SA
- SwitzerlandAceduo Leman, GelLeman SKL SA
- BelgiumAcnapalen 1 mg/g - 25 mg/gLaboratoires Bailleul
- BelgiumAcnapalen Forte 3 mg/g - 25 mg/gLaboratoires Bailleul
- NetherlandsAdabencutan 1 mg/g + 25 mg/g gelDermapharm AG
- NetherlandsAdabencutan 3 mg/g + 25 mg/g gelDermapharm AG
- SwitzerlandAdabencutan forte, GelDermapharm AG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2b43691-6798-4ada-a7f5-24033af0d4a1 GET /v1/drugs/e2b43691-6798-4ada-a7f5-24033af0d4a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Żel",
"source": "urpl",
"strength": "0,1% + 2,5%",
"packaging": "05909990642656 ¦ Rp ¦ 43008\n1 tuba 30 g\n05909990642663 ¦ Rp ¦ 43009\n1 tuba 60 g\n05909990652792 ¦ Rp ¦ 44364\n1 tuba 15 g\n05909991100148 ¦ Rp ¦ 88938\n1 poj. 15 ml\n05909991100155 ¦ Rp ¦ 88939\n1 poj. 30 g\n05909991100162 ¦ Rp ¦ 88940\n1 poj. 45 g\n05909991100179 ¦ Rp ¦ 88941\n1 poj. 60 g",
"substance": "Adapalenum 1 mg + Benzoylis peroxidum 25 mg",
"common_name": "Adapalenum + Benzoylis peroxidum",
"pl_product_id": "100192249",
"pozwolenie_nr": "14534",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about adapalen, kombinationen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.